Delivery Order SPE2DB20D2001-SPE2DB25FPMWK

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,211.54 and is a firm fixed-price delivery order without a set-aside designation. The period of performance for this order extends to July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The firm-fixed-price contract has a ceiling value of $17,503.46 and a period of performance through May 14, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,880.93 and covers the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,455.88 and a completion date of January 3, 2024. It is a firm-fixed-price contract awarded on January 2, 2024, with no set-aside requirements indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of valsartan-HCTZ 320-25 mg tablets in 90-count packages, with a ceiling value of $1,039.95 and a performance period extending to May 12, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The $6,429.84 firm-fixed-price contract has a completion date of February 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $6,087.44 and a period of performance through April 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles, with a ceiling value of $8,540.88. It is a delivery order contract with a firm fixed price. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The award has a ceiling value of $3,918.15 and a completion date of March 24, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,351.98, is for the delivery of Valsartan-HCTZ 320-25 mg tablets. It is a firm-fixed price delivery order contract with an ultimate completion date of April 2, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPMWK
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets, with a ceiling value of $20,117.59 and a performance period ending on June 6, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.

Generated 9/4/25, 10:03 AM